Prevalence of active Charcot disease in the East Midlands of England

Diabetic Medicine : a Journal of the British Diabetic Association
L MetcalfWilliam Jeffcoate

Abstract

To undertake a prospective point prevalence study of the prevalence of active Charcot neuro-inflammatory osteoarthropathy (Charcot disease) in a circumscribed part of England and to audit the time elapsing between disease onset and first diagnosis. The prevalence of active Charcot disease of the foot during a single month was assessed by specialist foot care teams at seven secondary care services in the East Midlands region of England. A total of 90 cases were identified, representing 4.3 per 10 000 of the 205 033 total diabetes population of the region. The time elapsed from first presentation to any healthcare professional until diagnosis was also assessed. While the diagnosis was suspected or confirmed in one-third of patients within 2 weeks, it was not made for 2 months or more in 23 patients (24%). Non-specialist professionals should have greater awareness of the existence of this uncommon complication of diabetes in the hope that earlier diagnosis will lead to lesser degrees of deformity.

References

Jan 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·J D Nabarro
Aug 27, 2011·Diabetes Care·Lee C RogersLuigi Uccioli
Mar 31, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·W J Jeffcoate
Oct 8, 2016·Irish Journal of Medical Science·A O'LoughlinR Canavan
May 14, 2017·Diabetes Research and Clinical Practice·Roberto AnichiniAlessandra De Bellis

❮ Previous
Next ❯

Citations

Mar 22, 2019·Diabetic Medicine : a Journal of the British Diabetic Association·K Taylor, S C Bain
Sep 25, 2018·Diabetic Medicine : a Journal of the British Diabetic Association·R I G Holt
Mar 9, 2021·Journal of Clinical Orthopaedics and Trauma·Michael EdmondsPrashanth Vas
Feb 3, 2021·Diabetes Care·Ole Lander SvendsenKristine Højgaard Allin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Related Papers

La Presse médicale
Fanny ReinhartDominique Stephan
MMW Fortschritte der Medizin
Hubert Stiegler
Diabetic Medicine : a Journal of the British Diabetic Association
A GazisWilliam Jeffcoate
Clinical Physiology and Functional Imaging
Tomas M ChristensenOle L Svendsen
© 2022 Meta ULC. All rights reserved